EXECUTIVE ENGAGEMENTS
POOL
2281
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
411
Interactions with Platform & by Email
PARTICIPANTS
68
Unique # Participated
VALIDATIONS
22
Responses Validated*
COMPANIES
44
Responses Validated*
* Login for a full stack data experience
DATE
APR 2021
TABLES
78
PAGES
152
EDITION
7
PRICE
USD 4950
CODE
MCP16205
*Engagement stats are ongoing and dynamic
HIGHLIGHTS & REPORT INDEX
Amid the COVID-19 crisis, the global market for Bioactive Wound Management estimated at US$1.3 Billion in the year 2020, is projected to reach a revised size of US$2.8 Billion by 2027, growing at a CAGR of 11.2% over the analysis period 2020-2027. Xenografts, one of the segments analyzed in the report, is projected to record a 11.7% CAGR and reach US$554.3 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Allografts segment is readjusted to a revised 12.3% CAGR for the next 7-year period.
The Bioactive Wound Management market in the U.S. is estimated at US$395.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$492 Million by the year 2027 trailing a CAGR of 10.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9.8% and 9.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.1% CAGR.
In the global Bioengineered Skin Substitutes segment, USA, Canada, Japan, China and Europe will drive the 10.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$194.4 Million in the year 2020 will reach a projected size of US$398.9 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$330.5 Million by the year 2027.
SELECT PLAYERS
3M Company; Acelity LP, Inc.; ACell Inc.; Convatec Group PLC; Covalon Technologies Ltd.; Integra LifeSciences Holdings Corporation; MiMedx Group, Inc.; Smith & Nephew PLC; SYMATESE; Wright Medical Group NV
SEGMENTS
» Application (Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds, Burn Wounds) » Product (Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings, Topical Dressings)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for Bioactive Wound Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Bioactive Wound Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027 |
| World Current & Future Analysis for Xenografts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Xenografts by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Allografts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Allografts by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Bioengineered Skin Substitutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Bioengineered Skin Substitutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Collagen-based Dressings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Collagen-based Dressings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Topical Dressings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Topical Dressings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Venous Leg Ulcers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Venous Leg Ulcers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Diabetic Foot Ulcers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Diabetic Foot Ulcers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Pressure Ulcers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Pressure Ulcers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Surgical Wounds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Surgical Wounds by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Burn Wounds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Burn Wounds by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| USA Current & Future Analysis for Bioactive Wound Management by Product - Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA 7-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings for the Years 2020 & 2027 |
| USA Current & Future Analysis for Bioactive Wound Management by Application - Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA 7-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds for the Years 2020 & 2027 |
| CANADA |
| Canada Current & Future Analysis for Bioactive Wound Management by Product - Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada 7-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings for the Years 2020 & 2027 |
| Canada Current & Future Analysis for Bioactive Wound Management by Application - Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada 7-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds for the Years 2020 & 2027 |
| JAPAN |
| Japan Current & Future Analysis for Bioactive Wound Management by Product - Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan 7-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings for the Years 2020 & 2027 |
| Japan Current & Future Analysis for Bioactive Wound Management by Application - Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan 7-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds for the Years 2020 & 2027 |
| CHINA |
| China Current & Future Analysis for Bioactive Wound Management by Product - Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China 7-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings for the Years 2020 & 2027 |
| China Current & Future Analysis for Bioactive Wound Management by Application - Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China 7-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds for the Years 2020 & 2027 |
| EUROPE |
| Europe Current & Future Analysis for Bioactive Wound Management by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Europe 7-Year Perspective for Bioactive Wound Management by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027 |
| Europe Current & Future Analysis for Bioactive Wound Management by Product - Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe 7-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings for the Years 2020 & 2027 |
| Europe Current & Future Analysis for Bioactive Wound Management by Application - Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe 7-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds for the Years 2020 & 2027 |
| FRANCE |
| France Current & Future Analysis for Bioactive Wound Management by Product - Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France 7-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings for the Years 2020 & 2027 |
| France Current & Future Analysis for Bioactive Wound Management by Application - Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France 7-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds for the Years 2020 & 2027 |
| GERMANY |
| Germany Current & Future Analysis for Bioactive Wound Management by Product - Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany 7-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings for the Years 2020 & 2027 |
| Germany Current & Future Analysis for Bioactive Wound Management by Application - Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany 7-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds for the Years 2020 & 2027 |
| ITALY |
| Italy Current & Future Analysis for Bioactive Wound Management by Product - Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy 7-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings for the Years 2020 & 2027 |
| Italy Current & Future Analysis for Bioactive Wound Management by Application - Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy 7-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds for the Years 2020 & 2027 |
| UNITED KINGDOM |
| UK Current & Future Analysis for Bioactive Wound Management by Product - Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK 7-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings for the Years 2020 & 2027 |
| UK Current & Future Analysis for Bioactive Wound Management by Application - Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK 7-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds for the Years 2020 & 2027 |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for Bioactive Wound Management by Product - Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe 7-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings for the Years 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Bioactive Wound Management by Application - Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe 7-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds for the Years 2020 & 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for Bioactive Wound Management by Product - Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific 7-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings for the Years 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Bioactive Wound Management by Application - Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific 7-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds for the Years 2020 & 2027 |
| REST OF WORLD |
| Rest of World Current & Future Analysis for Bioactive Wound Management by Product - Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World 7-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings for the Years 2020 & 2027 |
| Rest of World Current & Future Analysis for Bioactive Wound Management by Application - Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World 7-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds for the Years 2020 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 44 |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com